Multiple Myeloma
To view the entire topic, please log in or purchase a subscription.
5-Minute Clinical Consult (5MCC) app and website powered by Unbound Medicine helps you diagnose and manage 900+ medical conditions. Exclusive bonus features include Diagnosaurus DDx, 200 pediatrics topics, and medical news feeds. Explore these free sample topics:
-- The first section of this topic is shown below --
Basics
Description
- Multiple myeloma (MM) involves a malignant proliferation of a single clone of plasma cells.
- The malignant plasma cells produce monoclonal protein (immunoglobulin [Ig]) in the blood and urine as it is filtered in the kidneys.
- MM is characterized by bony lytic lesions, hypercalcemia, increased susceptibility to infections, and renal impairment.
- Monoclonal gammopathy of undetermined significance (MGUS) is a common disorder with limited monoclonal plasma cell proliferation that can progress to smoldering MM (SMM) or symptomatic MM at rate of ~1% per year.
Epidemiology
- MM affect the older adults with a median age of 65 to 74 years.
- Accounts for nearly 2% of all cancers and 17% of hematologic malignancies in the United States.
- African Americans about 2 to 3 times more commonly affected than Caucasians; less common in Asians
Incidence
7 cases per 100,000 in the United States annually
Prevalence
Etiology and Pathophysiology
- It is most likely related to genetic alteration involving chromosomal abnormalities and sporadic mutations.
- Genetic damage in developing B lymphocytes occur at time of isotype switching.
- Chromosomal abnormalities involve Ig heavy chain translocations, with cyclin D1 t(11;14) the most common and deletion of 17p13 (p53 locus) (2)[C].
Genetics
It occurs rarely in familial clusters. A rare form of paratarg-7 protein might have pathogenic role.
Risk Factors
- Most cases have no known risks associated.
- Old age; immunosuppression; and exposure to chemicals, heavy metals, and ionizing radiation increase the risk of MM.
Commonly Associated Conditions
Secondary amyloidosis commonly due to MM and polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes (POEMS)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Basics
Description
- Multiple myeloma (MM) involves a malignant proliferation of a single clone of plasma cells.
- The malignant plasma cells produce monoclonal protein (immunoglobulin [Ig]) in the blood and urine as it is filtered in the kidneys.
- MM is characterized by bony lytic lesions, hypercalcemia, increased susceptibility to infections, and renal impairment.
- Monoclonal gammopathy of undetermined significance (MGUS) is a common disorder with limited monoclonal plasma cell proliferation that can progress to smoldering MM (SMM) or symptomatic MM at rate of ~1% per year.
Epidemiology
- MM affect the older adults with a median age of 65 to 74 years.
- Accounts for nearly 2% of all cancers and 17% of hematologic malignancies in the United States.
- African Americans about 2 to 3 times more commonly affected than Caucasians; less common in Asians
Incidence
7 cases per 100,000 in the United States annually
Prevalence
Etiology and Pathophysiology
- It is most likely related to genetic alteration involving chromosomal abnormalities and sporadic mutations.
- Genetic damage in developing B lymphocytes occur at time of isotype switching.
- Chromosomal abnormalities involve Ig heavy chain translocations, with cyclin D1 t(11;14) the most common and deletion of 17p13 (p53 locus) (2)[C].
Genetics
It occurs rarely in familial clusters. A rare form of paratarg-7 protein might have pathogenic role.
Risk Factors
- Most cases have no known risks associated.
- Old age; immunosuppression; and exposure to chemicals, heavy metals, and ionizing radiation increase the risk of MM.
Commonly Associated Conditions
Secondary amyloidosis commonly due to MM and polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes (POEMS)
There's more to see -- the rest of this topic is available only to subscribers.